arrow
R

Ramón Palmero

l’hospitalet de llobregat
H指数:24
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study

简要报告:IPSOS III期研究中非小细胞肺癌铂类不适用性的事后验证

2025-07-220
PRE
Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study

Lurbinectedin联合Pembrolizumab治疗复发性小细胞肺癌: I/II期LUPER研究

2025-02-100
PRE
Impact of a proactive telephone intervention led by the advanced practice nurse aimed at symptom control and toxicity detection on the quality of life of outpatients with lung cancer undergoing treatment

由高级实践护士主导的、旨在症状控制和毒性检测的主动电话干预对接受治疗肺癌门诊患者生活质量的影响

2024-09-010
PRE
Impact of fecal microbiome on the efficacy of neoadjuvant chemo-immunotherapy and colitis adverse events: Findings from the NADIM II Trial
2024-03-220
PRE
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

一线阿特珠单抗单药治疗与单药化疗治疗不适合含铂方案 (IPSOS) 治疗的非小细胞肺癌患者: 一项3期,全球,多中心,开放标签,随机对照研究

LANCET
IF88.5
2023-08-0155
PRE
An eHealth ecosystem for stepped and early psychosocial care in advanced lung cancer: Rationale and protocol for a randomized control trial

用于晚期肺癌的阶梯式和早期社会心理护理的电子健康生态系统: 随机对照试验的原理和方案

2023-04-011
OAAI
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma
2021-09-2913
OA
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer

基于多重RNA的晚期非小细胞肺癌临床相关MET改变检测

2020-12-0720
OAAI